z-logo
Premium
Risankizumab versus ustekinumab for moderate‐to‐severe plaque psoriasis
Author(s) -
Fioranelli Massimo,
Roccia Maria Grazia,
Lotti Torello
Publication year - 2017
Publication title -
dermatologic therapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.595
H-Index - 68
eISSN - 1529-8019
pISSN - 1396-0296
DOI - 10.1111/dth.12507
Subject(s) - ustekinumab , medicine , psoriasis , classics , dermatology , art history , art , pathology , infliximab , disease

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom